Search

everythinglearnresearchcommunity

for

Search:↓

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

The animal models successfully simulated dry eye related to sex steroid deficiency.

Postmenopausal women with hair loss should get proper tests and consider treatments like minoxidil.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Prompt treatment of tinea capitis with oral antifungals leads to excellent recovery, but delayed care can cause permanent hair loss.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Menopause can cause oral health issues like dry mouth and burning sensations.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Asthma and high testosterone increase Covid-19 severity, while progesterone protects young women.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Testosterone is important for women's health, but more research is needed to guide its use.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.